Biotech Aquestive Therapeutics to Report Second Quarter 2022 Financial Results and Recent Business Highlights on August 2 and Host Conference Call on August 3 at 8:00 a.m. ET July 20, 2022
Biotech Aytu BioPharma Announces Initiation of the AR101 PREVEnt Trial for the Treatment of Vascular Ehlers-Danlos Syndrome July 20, 2022
Biotech Adial Pharmaceuticals Announces Topline Results For Onward(TM) Phase 3 Trial for AD04 in Patients with Alcohol Use Disorder July 20, 2022
Biotech Akari Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Pipeline Progress July 20, 2022
Biotech Capricor Therapeutics Announces First Patient Dosed in Pivotal Phase 3 Study of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy July 19, 2022
Biotech Celsion Corporation Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4) July 19, 2022
Biotech Allena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2a Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney Disease July 19, 2022
Search
biotech
July 20, 2022
July 20, 2022
July 20, 2022
July 20, 2022
July 20, 2022
July 19, 2022
July 19, 2022
July 19, 2022
July 19, 2022
July 19, 2022
